Relay Therapeutics
RLAY
Relay Therapeutics (RLAY) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| HC Wainwright & Co. | Maintained | Buy | $29.00 from $28.00 | Aug 20, 2026 |
| JP Morgan | Maintained | Overweight | $31.00 from $28.00 | Aug 14, 2026 |
| Citizens | Maintained | Market Outperform | $26.00 from $21.00 | Aug 10, 2026 |
| Barclays | Maintained | Overweight | $30.00 from $27.00 | Aug 7, 2026 |
| Goldman Sachs | Maintained | Buy | $31.00 from $22.00 | Jul 21, 2026 |
| Canaccord Genuity | Initiated Coverage | Buy | $29.00 | Jul 16, 2026 |
| JP Morgan | Initiated Coverage | Overweight | $28.00 | Jul 8, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $28.00 from $25.00 | May 26, 2026 |
| Guggenheim | Maintained | Buy | $26.00 from $22.00 | May 26, 2026 |
| Barclays | Maintained | Overweight | $27.00 from $21.00 | May 20, 2026 |
| Citizens | Maintained | Market Outperform | $21.00 from $19.00 | May 20, 2026 |
| Raymond James | Maintained | Strong Buy | $26.00 from $23.00 | May 19, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $25.00 from $19.00 | Apr 29, 2026 |
| Oppenheimer | Maintained | Outperform | $18.00 from $14.00 | Apr 28, 2026 |
| Wells Fargo | Maintained | Overweight | $21.00 from $17.00 | Apr 28, 2026 |
| Goldman Sachs | Maintained | Buy | $22.00 from $13.00 | Apr 28, 2026 |
| Citizens | Maintained | Market Outperform | $19.00 from $17.00 | Apr 28, 2026 |
| Jones Trading | Initiated Coverage | Hold | $18.00 | Apr 14, 2026 |
| Barclays | Maintained | Overweight | $21.00 from $17.00 | Apr 8, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $19.00 from $14.00 | Mar 23, 2026 |
Frequently asked questions
What is the latest analyst rating on RLAY?
On Aug 20, 2026, HC Wainwright & Co. maintained Relay Therapeutics at Buy with a price target of $29.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.